4.4 Article

Healthcare professionals' knowledge, attitude and acceptance of influenza vaccination in Saudi Arabia: a multicenter cross-sectional study

期刊

BMC HEALTH SERVICES RESEARCH
卷 19, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/s12913-019-4054-9

关键词

Healthcare professional; Influenza vaccination; Knowledge; Attitude; Saudi Arabia

向作者/读者索取更多资源

Background: All healthcare professionals (HCPs) are at high risk of influenza infection. Therefore, immunization is recommended for all HCPs. Due to safety and effectiveness concerns, HCPs have a low vaccination rate. This study was designed to explore the attitude, awareness and knowledge of HCPs toward vaccination for influenza. Method: A cross-sectional study was performed during October-November 2016. A total of 405 questionnaires were distributed in 8 major hospitals in Saudi Arabia. A validated questionnaire consisting of 31 questions and 5 sections was administered. Statistical Analysis Software (SAS (R)) version 9.2 was used to analyze the data. Results: A total of 364 HCPs responded to the study survey, which is a response rate of 90%. A large proportion (61.8%) of participants were female. The majority of the participants were nurses (60.4%). More than half of the respondents (57.7%) were working in government-run hospitals. Among all the participants, approximately 67.6% of HCPs were vaccinated. The majority (84.1%) of HCPs believed that influenza vaccine prevents the flu. Furthermore, approximately 75% of participants believed that HCPs can be more susceptible to influenza infections than other people. The majority of participants (89.6%) knew the proper signs and symptoms of influenza. HCPs' belief that vaccination prevents influenza infection (OR = 3.93, 95% CI = 1.97-7.82), their awareness of the Scientific Committee for Influenza and Pneumococcal Vaccination (SCIPV)'s guidelines (OR = 2. 13, 95% CI = 1.16-3.90) and the presence of the standing orders regarding influenza vaccine (OR = 1.57, 95% CI = 1.01-3.21), were the predictors for receipt of influenza vaccine by HCPs. Many (58.0%) respondents believed that vaccine safety concerns is a major barrier to the vaccination of HCPs. Some misconceptions, such as influenza infection due to vaccination (42.3%) and incorrect perceptions about the symptoms of influenza in adults (50.5%), were found. Conclusion: The acceptance of and participation in influenza vaccination by HCPs in Saudi Arabia appears to have markedly increased in the 2016 season. Continuing evaluation of vaccination practices is necessary, and more training programs are needed in the future.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Health Care Sciences & Services

Current Situation of Medication Errors in Saudi Arabia: A Nationwide Observational Study

Thamir M. Alshammari, Khalidah A. Alenzi, Yasser Alatawi, Afnan S. Almordi, Ali F. Altebainawi

Summary: This nationwide study quantifies the rate and level of harm from reported medication errors and identifies the stages of the medication process in which errors occur. It emphasizes the importance of pharmacists in reporting and detecting errors, and highlights the need for a blame-free culture and education for healthcare professionals to improve error reporting.

JOURNAL OF PATIENT SAFETY (2022)

Article Public, Environmental & Occupational Health

The impact of regulatory restrictions on pregabalin use in Saudi Arabia: An interrupted time series analysis

Turki A. Althunian, Maha Alomran, Ghada M. Alsagri, Meshael M. Alrasheed, Thamir M. Alshammari

Summary: The decision by SFDA led to a sharp decrease in the overall use of pregabalin in Saudi Arabia, indicating a successful attempt to minimize the risk of its abuse and misuse. Additionally, the decision resulted in an increase in the use of gabapentin without affecting the use of other drugs.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2022)

Article Pharmacology & Pharmacy

Efficacy and safety of delafloxacin, ceftaroline, ceftobiprole, and tigecycline for the empiric treatment of acute bacterial skin and skin structure infections: A network meta-analysis of randomized controlled trials

Abdullah A. Alhifany, Nisrin Bifari, Yasser Alatawi, Saad U. Malik, Thamer A. Almangour, Ali F. Altebainawi, Thamir M. Alshammari, Amal F. Alotaibi, Ahmad J. Mahrous, Fahad S. Alshehri, Ejaz Cheema

Summary: This study conducted an indirect comparison and found that delafloxacin had similar efficacy and safety as other single antibiotic regimens for the treatment of Acute Bacterial Skin and Skin Structure Infections. However, based on the evaluation results, delafloxacin was considered the first choice in the intention to treat population.

SAUDI PHARMACEUTICAL JOURNAL (2022)

Article Pharmacology & Pharmacy

Analyzing the US Post-marketing safety surveillance of COVID-19 vaccines

Omar M. Albalawi, Maha Alomran, Ghada M. Alsagri, Turki A. Althunian, Thamir M. Alshammari

Summary: This study examined the post-marketing safety profiles of three COVID-19 vaccines in the United States. The majority of reported adverse events were non-serious, and the number of serious adverse events was very low.

SAUDI PHARMACEUTICAL JOURNAL (2022)

Article Public, Environmental & Occupational Health

The Saudi Critical Care Society practice guidelines on the management of COVID-19 in the ICU: Therapy section

Waleed Alhazzani, Mohammed Alshahrani, Fayez Alshamsi, Ohoud Aljuhani, Khalid Eljaaly, Samaher Hashim, Rakan Alqahtani, Doaa Alsaleh, Zainab Al Duhailib, Haifa Algethamy, Tariq Al-Musawi, Thamir Alshammari, Abdullah Alqarni, Danya Khoujah, Wail Tashkandi, Talal Dahhan, Najla Almutairi, Haleema A. Alserehi, Maytha Al-Yahya, Bandar Al-Judaibi, Yaseen M. Arabi, Jameel Abualenain, Jawaher M. Alotaibi, Ali Al Bshabshe, Reham Alharbi, Fahad Al-Hameed, Alyaa Elhazmi, Reem S. Almaghrabi, Fatma Almaghlouth, Malak Abedalthagafi, Noor Al Khathlan, Faisal A. Al-Suwaidan, Reem F. Bunyan, Bandar Baw, Ghassan Alghamdi, Manal Al Hazmi, Yasser Mandourah, Abdullah Assiri, Mushira Enani, Maha Alawi, Reem Aljindan, Ahmed Aljabbary, Abdullah Alrbiaan, Fahd Algurashi, Abdulmohsen Alsaawi, Thamer H. Alenazi, Mohammed A. Alsultan, Saleh A. Alqahtani, Ziad Memish, Jaffar A. Al-Tawfiq, Ahmed Al-jedai

Summary: The Saudi Critical Care Society (SCCS) formed a panel of experts to issue evidence-based recommendations for the management of COVID-19 in the intensive care unit. They used the GRADE approach and evidence-to-decision framework to assess the quality of evidence and generate recommendations. The panel issued 12 recommendations on pharmacotherapeutic interventions for severe and critical COVID-19.

JOURNAL OF INFECTION AND PUBLIC HEALTH (2022)

Article Pharmacology & Pharmacy

Pharmacovigilance regulatory actions by national pharmacovigilance centers in Arab countries following COVID-19 pandemic

Sameh A. Al-Zubiedi, Manal Younus, Sara Al-Khalidi, Magnus Ekilo, Thamir M. Alshammari

Summary: The preparedness and performance of national pharmacovigilance systems in 14 Arab countries were impacted by COVID-19. There are significant differences in the preparedness and performance of national pharmacovigilance centers among participating countries. Improving digital infrastructure could be a useful tool to minimize the impact of the pandemic on pharmacovigilance activities.

EXPERT OPINION ON DRUG SAFETY (2023)

Article Pharmacology & Pharmacy

Promise of Real-World Evidence for Patient Centricity in Gulf Cooperation Council Countries: Call to Action

Mohamed Nasr Mahmoud Hassan Farghaly, Ibrahim Sulaiman Mas'oud Al Ghaithi, Wael Abdel Rahman Mahamid, Abdallah Adlan, Saleh Mohammed AlGhamdi, Thamir M. Al Shammari, Nasser Mohammed Alqahtani, Suliman A. Al Ghnam, Marie Sleiman Awad Ibrahim, Hajer Al Mudaiheem, Mohamed Zahir Chouikrat, Yahia Aktham, Marwan Essam El Bagoury, Arun Jayarame Gowda, Khalid Al Moaikel, Nancy Syed Awad Abdallah

Summary: Presently, Gulf Cooperation Council countries are lacking behind the global average in generating real-world data and utilizing real-world evidence for patient-centered care. Experts from various domains in these countries have presented their views and recommended key action points for the generation of robust real-world data and leveraging real-world evidence. Challenges in generating reliable and secure real-world evidence persist despite transformative changes. Thus, public-private engagements and collaborations are warranted to address these obstacles and achieve patient-centric benefits.

DRUGS-REAL WORLD OUTCOMES (2023)

Article Pharmacology & Pharmacy

Estimating the potential economic impact of the Wasfaty program on costs of antidiabetic treatment: An initiative for the digital transformation of health

Thamir M. Alshammari, Saud I. Alsubait, Khalidah A. Alenzi, Ziyad S. Almalki

Summary: The Saudi health care transformation is aiming to improve health care services by focusing on digitalization and privatization. This study evaluated the economic impact of implementing the new digital health transformation initiative (Wasfaty service) on the health care budget using diabetes mellitus as an example.

SAUDI PHARMACEUTICAL JOURNAL (2023)

Article Medicine, General & Internal

Recording type 2 diabetes mellitus in a standardised central Saudi database: a retrospective validation study

Turki Abdulaziz Althunian, Meshael M. Alrasheed, Fatemah A. Alnofal, Rawan T. Tafish, Mahmood A. Mira, Raseel A. Alroba, Mohammed W. Kirdas, Thamir M. Alshammari

Summary: This study assessed the validity of recording type 2 diabetes mellitus in a centralised database using a standardised common data model. The results showed high accuracy for most comparisons, except for sensitivity and specificity between the database and paper-based records.

BMJ OPEN (2023)

Review Critical Care Medicine

Saudi Critical Care Society clinical practice guidelines on the prevention of venous thromboembolism in adults with trauma: reviewed for evidence-based integrity and endorsed by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine

Marwa Amer, Mohammed S. Alshahrani, Yaseen M. Arabi, Ahmed Al-jedai, Hassan M. Alshaqaq, Abdulaziz Al-Sharydah, Faisal A. Al-Suwaidan, Hosam Aljehani, Thamer Nouh, Hassan Mashbari, Nehal Tarazan, Saad Alqahtani, Wail Tashkandi, Khalid Maghrabi, Muneerah Albugami, Samaher Hashim, Norah M. Alsubaie, Mohammad Alsenani, Haifa Algethamy, Thamir M. Alshammari, Ali Alaklabi, Nadia Ismail, Esraa S. Altawil, Alyaa Elhazmi, Ahmed Nahhas, Maha Aljuaid, Naif Alsadoon, Yasser Binbraik, Yuhong Yuan, Waleed Alhazzani

Summary: This article presents evidence-based clinical practice guidelines for venous thromboembolism (VTE) prevention in adults with trauma in inpatient settings. The guidelines were developed by a multidisciplinary panel and provide recommendations on the timing, type, and dose of pharmacologic and mechanical prophylaxis for VTE. The panel also suggests routine bilateral lower extremity ultrasonography for adults with trauma at elevated risk of VTE who are ineligible for pharmacologic prophylaxis.

ANNALS OF INTENSIVE CARE (2023)

Article Medicine, General & Internal

Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study

Erica A. Voss, Azza Shoaibi, Lana Yin Hui Lai, Clair Blacketer, Thamir Alshammari, Rupa Makadia, Kevin Haynes, Anthony G. Sena, Gowtham Rao, Sebastiaan van Sandijk, Clement Fraboulet, Laurent Boyer, Tanguy Le Carrour, Scott Horban, Daniel R. Morales, Jordi Martinez Roldan, Juan Manuel Ramirez-Anguita, Miguel A. Mayer, Marcel de Wilde, Luis H. John, Talita Duarte-Salles, Elena Roel, Andrea Pistillo, Raivo Kolde, Filip Maljkovic, Spiros Denaxas, Vaclav Papez, Michael G. Kahn, Karthik Natarajan, Christian Reich, Alex Secora, Evan P. Minty, Nigam H. Shah, Jose D. Posada, Maria Teresa Garcia Morales, Diego Bosca, Honorio Cadenas Juanino, Antonio Diaz Holgado, Miguel Pedrera Jimenez, Pablo Serrano Balazote, Noelia Garcia Barrio, Selcuk Sen, Ali Yagiz ueresin, Baris Erdogan, Luc Belmans, Geert Byttebier, Manu L. N. G. Malbrain, Daniel J. Dedman, Zara Cuccu, Rohit Vashisht, Atul J. Butte, Ayan Patel, Lisa Dahm, Cora Han, Fan Bu, Faaizah Arshad, Anna Ostropolets, Fredrik Nyberg, George Hripcsak, Marc A. Suchard, Dani Prieto-Alhambra, Peter R. Rijnbeek, Martijn J. Schuemie, Patrick B. Ryan

Summary: This study aimed to compare the incidence rates of specific adverse events of interest (AESIs) after COVID-19 infection with historical rates in the general population. The findings showed a significant increase in AESIs after COVID-19, with thromboembolic events being particularly common.

ECLINICALMEDICINE (2023)

Review Pharmacology & Pharmacy

Impact of risk communication on patient's safety during the pandemic

Heyde-Patricia Zuluaga-Arias, Mayada Alkhakany, Manal M. Younus, Houda Sefiani, Angela Caro-Rojas, Sameh Al-Zubiedi, Wafi F. Albalawi, Thamir M. Alshammari

Summary: More than 2 years have passed since the declaration of the COVID-19 pandemic, during which healthcare systems faced numerous challenges. Unlike previous pandemics, actions against this pandemic started quickly on a global and national level. However, the pandemic also led to an infodemic, with limited and contradictory information on drugs and vaccines, making risk assessment difficult for public health agencies.

THERAPEUTIC ADVANCES IN DRUG SAFETY (2023)

Article Pharmacology & Pharmacy

Association between proton pump inhibitors and rhabdomyolysis risk: a post-marketing surveillance using FDA adverse event reporting system (FAERS) database

Ali F. Altebainawi, Lulwa A. Alfaraj, Amjad A. Alharbi, Fadwa F. Alkhuraisi, Thamir M. Alshammari

Summary: This research explores and compares the signals of rhabdomyolysis from the use of Proton pump inhibitors (PPIs) using the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database. The study finds significant signals of rhabdomyolysis associated with PPIs, particularly in non-statin reports.

THERAPEUTIC ADVANCES IN DRUG SAFETY (2023)

Meeting Abstract Public, Environmental & Occupational Health

Pharmacovigilance education in pharmacy programs' curricula in Saudi Arabia

Mona Y. Alsheikh, Ahmed I. Fathelrahman, Thamir M. Alshammari

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2022)

Meeting Abstract Public, Environmental & Occupational Health

Validating the standardized and ICD-9 code of type 2 diabetes mellitus in a Saudi common data model

Turki A. I. Althunian, Meshael Alrasheed, Fatemah Alnofal, Rawan Tafish, Mahmood A. Mira, Raseel A. Alroba, Mohammed Kirdas, Thamir M. Alshammari

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2022)

暂无数据